Balchem Corporation

NasdaqGS BCPC

Balchem Corporation Current Liabilities for the quarter ending September 30, 2024: USD 109.44 M

Balchem Corporation Current Liabilities is USD 109.44 M for the quarter ending September 30, 2024, a 1.30% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Balchem Corporation Current Liabilities for the quarter ending September 30, 2023 was USD 108.04 M, a -23.96% change year over year.
  • Balchem Corporation Current Liabilities for the quarter ending September 30, 2022 was USD 142.09 M, a 35.41% change year over year.
  • Balchem Corporation Current Liabilities for the quarter ending September 30, 2021 was USD 104.93 M, a 53.37% change year over year.
  • Balchem Corporation Current Liabilities for the quarter ending September 30, 2020 was USD 68.41 M, a -5.01% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
SV Wall Street
NasdaqGS: BCPC

Balchem Corporation

CEO Mr. Theodore L. Harris
IPO Date June 3, 1986
Location United States
Headquarters 52 Sunrise Park Road
Employees 1,300
Sector Consumers Staples
Industries
Description

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

Similar companies

AXTA

Axalta Coating Systems Ltd.

USD 35.94

-2.52%

KWR

Quaker Chemical Corporation

USD 141.18

0.19%

CBT

Cabot Corporation

USD 86.47

-0.88%

ODC

Oil-Dri Corporation of America

USD 42.02

-1.34%

SXT

Sensient Technologies Corporation

USD 75.51

-0.05%

FUL

H.B. Fuller Company

USD 63.13

-0.60%

MTX

Minerals Technologies Inc.

USD 76.69

-0.73%

ASH

Ashland Inc.

USD 63.49

-0.39%

IOSP

Innospec Inc.

USD 113.35

-1.96%

StockViz Staff

February 3, 2025

Any question? Send us an email